All Stories

  1. HPV-16 viral load in oropharyngeal squamous cell carcinoma using digital PCR
  2. Validation of a risk prediction model for Barrett’s esophagus in an Australian population
  3. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013
  4. Response to: M.F. Holick ‘Can you have your cake and eat it too? The sunlight D-lema’
  5. Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison
  6. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study
  7. Cancers in Australia in 2010 attributable to inadequate consumption of fruit, non-starchy vegetables and dietary fibre
  8. Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview
  9. Cancers in Australia in 2010 attributable to insufficient physical activity
  10. Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use
  11. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions
  12. Sun Protection and Skin Examination Practices in a Setting of High Ambient Solar Radiation
  13. Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett’s Esophagus in a Population-Based Case-Control Study
  14. Association between Helicobacter pylori and pancreatic cancer risk: A meta-analysis
  15. Race/Ethnicity and the Prevalence of Thyrotoxicosis in Young Americans
  16. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia
  17. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis
  18. Independent Validation of Six Melanoma Risk Prediction Models
  19. Basal cell carcinomas on sun-protected vs. sun-exposed body sites: a comparison of phenotypic and environmental risk factors
  20. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma
  21. 119 Gastroesophageal Reflux Modifies the Risk of Barrett's Esophagus Associated With the Metabolic Effects of Obesity
  22. Human papillomavirus status and p16INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia
  23. More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
  24. MIC-1/GDF15 in Barrett’s oesophagus and oesophageal adenocarcinoma
  25. The Feasibility of an Exercise Intervention in Males at Risk of Oesophageal Adenocarcinoma: A Randomized Controlled Trial
  26. A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer
  27. Smoking behaviour modifiesIL23r-associated disease risk in patients with Crohn's disease
  28. Solar elastosis and cutaneous melanoma: A site-specific analysis
  29. A case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer Study
  30. Predicting melanoma risk: theory, practice and future challenges
  31. High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett’s Esophagus and Adenocarcinoma
  32. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma
  33. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer
  34. Abstract 2492: Discovery and validation of novel serum glycoprotein biomarkers for Barrett's esophagus and esophageal adenocarcinoma
  35. Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)
  36. Alcohol and the Risk of Barrett's Esophagus: A Pooled Analysis from the International BEACON Consortium
  37. Esophageal Cancer: Priorities for Prevention
  38. Total body fat and the risk of Barrett's oesophagus – A bioelectrical impedance study
  39. Prognostic value of BRAF mutations in localized cutaneous melanoma
  40. Does a prior diagnosis of Barrett's oesophagus influence risk of dying from oesophageal adenocarcinoma?
  41. Clinical Skin Examination Outcomes After a Video-Based Behavioral Intervention
  42. Prevalence and Risk Factors for Oral HPV Infection in Young Australians
  43. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
  44. Measuring Exposure to Solar Ultraviolet Radiation Using a Dosimetric Technique: Understanding Participant Compliance Issues
  45. Cigarette smoking and pancreatic cancer risk: More to the story than just pack-years
  46. The Contributions of Solar Ultraviolet Radiation Exposure and Other Determinants to Serum 25-Hydroxyvitamin D Concentrations in Australian Adults: The AusD Study
  47. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus
  48. Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer
  49. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin
  50. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption
  51. The effect ofMC1Rvariants and sunscreen on the response of human melanocytes in vivo to ultraviolet radiation and implications for melanoma
  52. Can we really predict risk of cancer?
  53. Cutaneous Markers of Photo-Damage and Risk of Basal Cell Carcinoma of the Skin: A Meta-Analysis
  54. Cost-Effectiveness Of Radiofrequency Ablation Compared To Endoscopic Surveillance For Patients With Barrett's Esophagus With Low Grade Dysplasia
  55. Mo1911 Cost-Effectiveness of Radiofrequency Ablation Compared to Endoscopic Surveillances for Patients With Barrett's Esophagus With Low Grade Dysplasia
  56. Tu1770 Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study
  57. Determinants of Uptake of Whole-Body Skin Self-Examination in Older Men
  58. NRAS and BRAF Mutations in Cutaneous Melanoma and the Association with MC1R Genotype: Findings from Spanish and Austrian Populations
  59. Prognostic sub-classifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark level of invasion. Results of a population-based study from the Swedish Melanoma Register
  60. Prevalence of BRAF and NRAS mutations in fast-growing melanomas
  61. Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population
  62. A Model to Determine Absolute Risk for Esophageal Adenocarcinoma
  63. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium
  64. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
  65. Abstract B100: Association between ambient ultraviolet radiation and risk of esophageal cancer
  66. The risk of Barrett's esophagus associated with abdominal obesity in males and females
  67. Surgical management in patients with pancreatic cancer: a Queensland perspective
  68. Association Between Ambient Ultraviolet Radiation and Risk of Esophageal Cancer
  69. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends
  70. A Clinical Risk Prediction Model for Barrett Esophagus
  71. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium
  72. Modeling the Cost-effectiveness of Strategies for Treating Esophageal Adenocarcinoma and High-grade Dysplasia
  73. Cigarette Smoking Increases Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium
  74. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival
  75. InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers
  76. Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
  77. Update on melanoma and non-melanoma skin cancer
  78. Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community
  79. The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett’s oesophagus
  80. Polymorphisms in Nevus-Associated Genes MTAP, PLA2G6, and IRF4 and the Risk of Invasive Cutaneous Melanoma
  81. Dietary patterns and risk of oesophageal cancers: a population-based case–control study
  82. Body mass index, long-term weight change, and esophageal squamous cell carcinoma
  83. Helicobacter pylori infection and the risks of Barrett's oesophagus: A population-based case-control study
  84. Healthcare resource use and medical costs for the management of oesophageal cancer
  85. Population Attributable Fractions of Adenocarcinoma of the Esophagus and Gastroesophageal Junction
  86. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice
  87. Physical activity and cancer prevention: a systematic review of clinical trials
  88. Melanocortin 1 receptor and risk of cutaneous melanoma: A meta-analysis and estimates of population burden
  89. Lifetime Alcohol Consumption and Risk of Barrett's Esophagus
  90. Barrett's esophagus
  91. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium
  92. Nevi, Family History, and Fair Skin Increase the Risk of Second Primary Melanoma
  93. High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma--Response
  94. ‘Blue Sky’ epidemiology: definition, examples and a plea for understanding
  95. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations
  96. High Intake of Folate from Food Sources Is Associated with Reduced Risk of Esophageal Cancer in an Australian Population
  97. Esophageal Adenocarcinoma Incidence in Individuals With Gastroesophageal Reflux: Synthesis and Estimates From Population Studies
  98. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium
  99. High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma
  100. Association of Helicobacter pylori Infection With Reduced Risk for Esophageal Cancer Is Independent of Environmental and Genetic Modifiers
  101. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: A pooled analysis
  102. Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus
  103. Melanoma screening: The Australian perspective
  104. Genes, sunlight and the origins of cutaneous melanoma
  105. Tea consumption and risk of ovarian cancer
  106. Eating habits and risk of esophageal cancers: a population-based case–control study
  107. Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis
  108. Foveolar type dysplasia in Barrett esophagus
  109. A survey of sunscreen use and sun-protection practices in Darwin
  110. Estimating the attributable fraction for melanoma: A meta-analysis of pigmentary characteristics and freckling
  111. Hyperplastic Polyposis Syndrome Is Associated With Cigarette Smoking, Which May Be a Modifiable Risk Factor
  112. Estimating the Attributable Fraction for Cancer: A Meta-analysis of Nevi and Melanoma
  113. Abstract CN12-02: Towards the control of melanoma
  114. Epidemiology of Malignant Melanoma
  115. The skin awareness study: Promoting thorough skin self-examination for skin cancer among men 50years or older
  116. Familial Melanoma: A Meta-analysis and Estimates of Attributable Fraction
  117. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
  118. Esophageal cancer in Indigenous Australians in Far North Queensland
  119. Breastfeeding and risk of epithelial ovarian cancer
  120. Life course sun exposure and risk of prostate cancer: Population-based nested case-control study and meta-analysis
  121. A Population-Based Study of Australian Twins with Melanoma Suggests a Strong Genetic Contribution to Liability
  122. Current and Past Smoking Significantly Increase Risk for Barrett's Esophagus
  123. Do low control response rates always affect the findings? Assessments of smoking and obesity in two Australian case-control studies of cancer
  124. Beyond Parity: Association of Ovarian Cancer With Length of Gestation and Offspring Characteristics
  125. T1063 Incidence of Esophageal Adenocarcinoma in Patients with Gastroesophageal Reflux in Context of Other Screened Cancers
  126. Erratum: Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
  127. Alcohol Consumption and the Risks of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus
  128. Hot tea and increased risk of oesophageal cancer
  129. Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
  130. Factors Associated With the Number of Lesions Excised for Each Skin Cancer
  131. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas
  132. Epithelial ovarian cancer: testing the 'androgens hypothesis'
  133. Prevalence and correlates of multiple cancer risk behaviors in an Australian population-based survey: results from the Queensland Cancer Risk Study
  134. Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas
  135. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
  136. Associations of Duration, Intensity, and Quantity of Smoking with Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus
  137. Body size and risk of epithelial ovarian and related cancers: A population-based case-control study
  139. Cancers of the esophagus and carbonated beverage consumption: a population-based case–control study
  140. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
  141. Leptin and the risk of Barrett's oesophagus
  142. Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis
  143. Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systematic Review, and Meta-analysis
  144. Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum?
  145. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus
  146. Sun protection and low levels of vitamin D: are people concerned?
  147. HPV vaccination: what do Queensland parents think?
  148. Basal cell carcinoma on the trunk is associated with excessive sun exposure
  149. Risk Factors for Benign Serous and Mucinous Epithelial Ovarian Tumors
  150. Hypothesis: hair cover can protect against invasive melanoma on the head and neck (Australia)
  151. Does smoking increase risk of ovarian cancer? A systematic review
  152. Solar Radiation
  153. Anatomical distribution of solar ultraviolet exposures among cyclists
  154. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis
  155. The Queensland Cancer Risk Study: behavioural risk factor results
  156. Diagnostic accuracy in skin cancer clinics: the Australian experience
  157. Anatomic Site, Sun Exposure, and Risk of Cutaneous Melanoma
  158. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin
  159. Site-specific occurrence of nonmelanoma skin cancers in patients with cutaneous melanoma
  160. A Risk Prediction Tool for Melanoma?
  161. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia)
  162. Melanocytic nevi in very young children: The role of phenotype, sun exposure, and sun protection
  163. Twinning and the Incidence of Breast and Gynecological Cancers (United States)
  164. RESPONSE: Re: A Prospective Study of Pigmentation, Sun Exposure, and Risk of Cutaneous Malignant Melanoma in Women
  165. The role of genetics in the prevention of skin cancer
  166. RESPONSE: Re: Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
  167. Prevalence and anatomical distribution of naevi in young Queensland children
  168. Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
  169. Induction of Metallothionein in Human Skin by Routine Exposure to Sunlight: Evidence for a Systemic Response and Enhanced Induction at Certain Body Sites
  170. A rapid method for determining recent sunscreen use in field studies
  171. Loss of p16 expression is associated with histological features of melanoma invasion
  172. Epithelial Ovarian Carcinoma and Fertility of Parents
  173. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma
  174. RESPONSE: Re: Multiple Births and Risk of Epithelial Ovarian Cancer
  175. Childhood cancer incidence in a cohort of twin babies
  176. Reproductive Factors, Subfertility, and Risk of Neural Tube Defects: A Case-Control Study Based on the Oxford Record Linkage Study Register
  177. Multiple Births and Risk of Epithelial Ovarian Cancer
  178. Sunlight and health
  179. Determinants of melanocyte density in adult human skin
  180. Screening for ovarian cancer
  181. Melanoma and sun exposure: where are we now?
  182. Sun Exposure, Skin Cancers and Related Skin Conditions
  183. p53 expression and risk factors for cutaneous melanoma: A case-control study
  184. History of tropical military service and risk of primary cutaneous melanoma in Queensland men
  185. Germline CDKN2A Mutations in Childhood Melanoma
  186. O XVIII A.3 Epidemiology and prevention of skin cancer in Queensland
  187. P53 expression, phenotype and risk of melanoma
  188. Melanoma??s variable association with sun exposure
  189. Risk factors for childhood melanoma in Queensland, Australia
  190. Risk factors for childhood melanoma in Queensland, Australia
  191. Incidence of cutaneous childhood melanoma in Queensland, Australia
  192. Melanoma and sun exposure
  193. Melanoma and sunburn
  194. Sunburn and melanoma: how strong is the evidence?
  195. Divergent Pathways to Cutaneous Melanoma